Pennsylvania insurers won't cover Alzheimer's drug Leqembi

Some private insurers in Pennsylvania are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.

Related Keywords

Cheektowaga ,New York ,United States ,West Virginia ,Boston ,Massachusetts ,Japan ,Tufts Medical Center ,Cambridge ,Cambridgeshire ,United Kingdom ,Pennsylvania ,Delaware ,North Carolina ,Japanese ,Greg Warren ,Kaiser Permanente ,Heidi Syropoulos ,Juliette Cubanski ,James Chambers ,Christine Mann ,Jack Hoadley ,Bonnie Bortz ,N Dent Neurologic Institute ,Biogen Inc ,Society Of Actuaries ,Drug Administration ,Georgetown University Center On Health Insurance Reforms ,Associated Press ,Elevance Health ,Massachusetts Based Biogen ,Dent Neurologic Institute ,Blue Cross ,Blue Shield ,Philadelphia Based Independence Blue ,Blue Cross Shield ,Medicare Advantage ,Medical Center ,Georgetown University ,Health Insurance ,